Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN

BlackRock, Inc. reported a 5.80% stake in Eledon Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 27, 2026

BlackRock, Inc. reported a 5.80% stake in Eledon Pharmaceuticals, Inc., 4,380,857 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G).

Stake
5.80%
Shares
4,380,857
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.80%4,380,857

Source

View original at SEC

Related